Byron Nash Renal Medullary Carcinoma Awareness Act of 2021

United States117th CongressHR-124House of Representatives
Updated: Feb 2, 2021

Summary

Byron Nash Renal Medullary Carcinoma Awareness Act of 2021 This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

  1. Introduced in House

  2. Referred to the House Committee on Energy and Commerce.

    House of Representatives

  3. Referred to the Subcommittee on Health.

    House of Representatives

All available records shown.